Findings identify strategy for boosting anticancer immunity and potentially a new tool for delivering genetic payloads to ...

By deploying a "tag and sort" fix using E3 ligases, scientists successfully cleared the protein buildup and restored T-cell ...

Advanced non-viral gene delivery systems are expanding the range of indications and therapy modalities possible for the new generation of genetic medicines.

Companies are adopting diverse approaches to reducing unwanted toxicities associated with cell and gene therapy.

New solutions include customized reagents that scale from bench to clinical trials, industrialized lentiviral vector ...

IDT played a pivotal role in manufacturing the personalized gene editing therapy given to baby KJ Muldoon to treat his rare ...

The right approaches are demonstrating that it is possible to breach the defensively designed blood-brain barrier despite its ...

Study finds that a classically anaerobic bacterium, ETBF, can benefit from, and even help create, an oxygen-rich environment.

As more products reach the market, therapy developers partner with researchers and regulators to deliver N-of-1 treatments to patients.

Shifting brain glucose levels act as a metabolic switch that directs OPC proliferation and myelin formation, revealing a mechanism with developmental and clinical implications.

This highly conserved protein is largely overlooked by researchers but is at the core of immune functions, helping regulate ...

Venter advanced efforts to translate genomics and synthetic biology into the tools for the benefits of human health.